Scorpius Holdings Inc (SCPX) Stock
Scorpius stock price chart
SCPX stock quote & key statistics
Scorpius annual financials
Income statement →| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2024 | $6.2M | -$32.8M | — |
| FY2023 | $7.0M | -$45.2M | -$206.68 |
| FY2022 | $6.0M | -$43.4M | -$314.66 |
| FY2021 | $2.1M | -$35.1M | -$174.54 |
| FY2020 | $2.9M | -$26.0M | -$269.94 |
Fiscal year ending December 31. Source: company filings via EODHD.
About Scorpius Holdings Inc
Scorpius Holdings, Inc., through its subsidiary Scorpius BioManufacturing, operates as an integrated contract development and manufacturing organization. The company engages in clinical and commercial drug substance manufacturing; and release and stability testing activities. It is also involved in the provision of various process development services, including upstream and downstream development and optimization, and analytical method development solutions, as well as cell line development, testing, and characterization services.
The company serves the biotechnology and biopharmaceutical industries. The company was formerly known as NightHawk Biosciences, Inc. and changed its name to Scorpius Holdings, Inc. in February 2024. Scorpius Holdings, Inc. was incorporated in 2008 and is based in San Antonio, Texas.
Scorpius stock FAQ
What is the Scorpius stock ticker symbol?
Scorpius Holdings Inc trades on the NYSE American under the ticker symbol SCPX.
What sector and industry is Scorpius in?
Scorpius Holdings Inc is classified in the Healthcare sector, Biotechnology industry.
How many employees does Scorpius have?
Scorpius Holdings Inc has about 90 full-time employees.
What were Scorpius's revenue and earnings last fiscal year?
Scorpius reported revenue of $6.2M and net income of -$32.8M in fiscal 2024. Revenue declined 10.7% from the prior year.
When did Scorpius go public?
Scorpius stock began trading on July 24, 2013.
Biotechnology stocks
All Healthcare stocks →- ACADACADIA Pharmaceuticals
- ALNYAlnylam
- ARWRArrowhead Pharmaceuticals
- ASNDAscendis Pharma A/S
- BMRNBioMarin Pharmaceutical
- CAICaris Life Sciences
- CORTCorcept Therapeutics
- EXELExelixis
- FTREFortrea
- HALOHalozyme Therapeutics
- HRMYHarmony Biosciences
- INCYIncyte
- IONSIonis Pharmaceuticals
- JAZZJazz Pharmaceuticals
- MDGLMadrigal Pharmaceuticals
- MRNAModerna
- NVAXNovavax
- PTCTPTC Therapeutics
- RAREUltragenyx Pharmaceutical
- REGNRegeneron
- RPRXRoyalty Pharma
- SRPTSarepta Therapeutics
- TECHBio-Techne
- VRTXVertex